Home arrow Products arrow E arrow EQUI-PHAR FUROSEMIDE INJECTION
EQUI-PHAR FUROSEMIDE INJECTION Print E-mail
0109-01.jpg5%
Diuretic
NADA No.: 131-538, Approved by FDA
Click here for MSDS

Active Ingredients:

Each mL contains:
Furosemide (as a monoethanolamine salt) 50 mg
Myristyl-gammapicolinium chloride 0.02%
EDTA sodium 0.1%
Sodium sulfite 0.1%
Sodium chloride 0.2%
Water for injection. The pH is adjusted with sodium hydroxide.

Indications:

Furosemide Injectionis an effective diuretic-saluretic for use in the treatment of acute noninflammatory tissue edema in dogs and horses and for use in the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency in the dog.

Dosage and Administration:

Administer either intramuscularly or intraveneously; DOGS: 0.25 to 0.50 mL per 10 pounds body weight once or twice daily at 6 to 8 hour intervals. HORSES: Approximately 0.50 mg/lb body weight (1.0 mg/kg) once or twicw daily at 6 to 8 hour intervals.
 A prompt diuresis usually ensues from the initial treatment. Diuresis may be initiated by the parenteral administration of Furosemide Injection. The dose should be adjusted according to the individual’s response. In severe edematous or refractory cases, the dose may be doubled or increased by increments of 1 mg per pound of body weight. The established effective dose should be administered once or twice a day. The daily schedule of administration can be timed to control the period of micturition for the convenience of the client or veterinarian. Mobilization of the edema may be most efficiently and safely accomplished by utilizing an intermittent daily dosage schedule, i.e., every other day, or two (2) to four (4) consecutive days a week. Diuretic therapy should be discontinued after reduction of the edema or maintained after determining a carefully programmed dosage schedule to prevent recurrence of edema. For long-term treatment, the dose can generally be lowered after the edema has once been reduced. Re-examination and consultations with the client will enhance the establishment of a satisfactorily programmed dosage schedule. Clinical examination and serum BUN, CO2 and electrolyte determination should be performed during the early period of therapy and periodically thereafter, especially in refractory cases. Abnormalities should be corrected or the drug temporarily withdrawn.

Precautions:

Do not store above 25°C (77°F).

Cautions:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

SOLD TO VETERINARIANS ONLY.
FOR VETERINARY USE ONLY.

Warnings:

Do not use in horses intended for food.

Presentation:

100 mL sterile multiple dose vials.
50 mL sterile multiple dose vials.

VEDCO - 11/10/98.1
 
< Prev   Next >

Company address

Vedco Inc. 
5503 Corporate Drive
Saint Joseph MO 64507
(816) 238-8840